ArticleData in brief2025
Data showing effects of resolvin D
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Human seminal plasma suppresses neutrophil antimicrobial functions and promotes bacterial survival.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regulation of the reactive oxygen species (ROS) producing NADPH oxidase, expressed in neutrophils, is essential for a balance between the proinflammatory antimicrobial host defence and the resolving reactivity that limits tissue destructing inflammatory processes. Peripheral blood neutrophils of healthy adults were isolated from buffy coats obtained from the blood bank at Sahlgrenska University Hospital, using a standard density-gradient centrifugation protocol. The neutrophils were activated by fMet-Leu-Phe (fMLF) a peptide recognized by formyl peptide receptor 1 (FPR1). Signals generated downstream of the agonist occupied FPR1 activate the NADPH oxidase in the neutrophil plasma membrane. The release of ROS by fMLF activated neutrophils was measured in real time using a very sensitive isoluminol-amplified chemiluminescence system, expressed in light units (Mega counts per minute; Mcpm), and the peak value levels of the responses were determined. The activation signals generated by FPR1 were inhibited (reduced peak values) by the agonist occupied EP
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.